These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27710140)

  • 41. Invasive Fungal Disease Among Pediatric and Adolescent Patients Undergoing Itraconazole Prophylaxis After Hematopoietic Stem Cell Transplantation.
    Itsaradisaikul S; Pakakasama S; Boonsathorn S; Techasaensiri C; Rattanasiri S; Apiwattanakul N
    Transplant Proc; 2021; 53(6):2021-2028. PubMed ID: 33994183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for invasive fungal infections in haematopoietic stem cell transplantation.
    Camps IR
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S119-23. PubMed ID: 19013335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive Fungal Disease in Pediatric Solid Organ Transplant Recipients.
    Saxena S; Gee J; Klieger S; Kajon A; Petersen H; Zaoutis T; Fisher B
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):219-225. PubMed ID: 28992290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary antifungal prophylaxis: decrease of invasive fungal disease incidence and reduction of risk factors in haematological patients in a 5-year retrospective study.
    Li Y; Liu M; Zhai B; Zhao X; Wang L; Li H; Wang S; Zhu H; Wang Q; Gao C; Huang W; Yu L
    Intern Med J; 2018 Jun; 48(6):713-720. PubMed ID: 29230923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical considerations in the early treatment of invasive mould infections and disease.
    Mercier T; Maertens J
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i29-i38. PubMed ID: 28355465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Empirical antifungal treatment for diagnosed and undiagnosed invasive fungal disease in patients with hematologic malignancies.
    Deng Q; Lv HR; Lin XM; Zhao MF; Geng L; Li YM
    Curr Med Res Opin; 2018 Jul; 34(7):1209-1216. PubMed ID: 28956459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prophylaxis of fungal infections in haematological patients: pro].
    Glass B
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1870. PubMed ID: 20842607
    [No Abstract]   [Full Text] [Related]  

  • 49. How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.
    Puerta-Alcalde P; Champlin RE; Kontoyiannis DP
    Blood; 2020 Dec; 136(24):2741-2753. PubMed ID: 33301030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of caspofungin and itraconazole as secondary antifungal prophylaxis: analysis of data from a multinational case registry.
    Vehreschild JJ; Sieniawski M; Reuter S; Arenz D; Reichert D; Maertens J; Böhme A; Silling G; Martino R; Maschmeyer G; Rüping MJ; Ullmann AJ; Cornely OA
    Int J Antimicrob Agents; 2009 Nov; 34(5):446-50. PubMed ID: 19700265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. When to Use Prophylactic Antibiotics in Neutropenic Patients.
    Zimmer A; Freifeld A
    Oncology (Williston Park); 2016 Sep; 30(9):838-40, 846. PubMed ID: 27633416
    [No Abstract]   [Full Text] [Related]  

  • 52. Reduction in incidence of invasive fungal infection in patients receiving allogeneic stem cell transplantation using combined diagnostic-driven approach and itraconazole oral solution.
    Tzadok R; Shapira MY; Moses AE; Or R; Block C; Strahilevitz J
    Mycoses; 2015 Dec; 58(12):694-8. PubMed ID: 26429354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Invasive Aspergillosis in Hematological Patients].
    Kimura S
    Med Mycol J; 2016; 57(2):J77-88. PubMed ID: 27251320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
    Salavert M; Jarque I
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():43-9. PubMed ID: 21420577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations.
    Pagano L; Busca A; Candoni A; Cattaneo C; Cesaro S; Fanci R; Nadali G; Potenza L; Russo D; Tumbarello M; Nosari A; Aversa F; ;
    Blood Rev; 2017 Mar; 31(2):17-29. PubMed ID: 27682882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triggers for driving treatment of at-risk patients with invasive fungal disease.
    Drgona L; Colita A; Klimko N; Rahav G; Ozcan MA; Donnelly JP
    J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii17-iii24. PubMed ID: 24155142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study.
    Wang L; Wang Y; Hu J; Sun Y; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X
    Front Med; 2019 Jun; 13(3):365-377. PubMed ID: 30604166
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.